Sergio Quijano, MD
Gastroenterology · Cumming, GANPI 1609033216
Payments from drug & device makers
Across 264 payments — averaging $33.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ipsen Biopharmaceuticals, Inc$2K
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Johnson & Johnson$557
- Takeda Pharmaceuticals U.S.A., Inc.$432
- Gilead$296
- plus $1K from 23 others
What the payments were for
- Speaking & faculty fees$2,16024%
- Food & beverage$6,52473%
- Education$2373%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 4 | $2,393 |
| AbbVie(2 entities) | 89 | $2,058 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 56 | $1,704 |
| Johnson & Johnson(2 entities) | 23 | $557 |
| Takeda Pharmaceuticals U.S.A., Inc. | 25 | $432 |
| Gilead | 6 | $296 |
| Boston Scientific | 3 | $186 |
| Madrigal Pharmaceuticals | 1 | $139 |
| E.r. Squibb & Sons, L.L.C. | 2 | $132 |
| Pfizer | 7 | $132 |
| Bristol Myers Squibb | 6 | $121 |
| Romark Laboratories, LC | 7 | $113 |
| QOL Medical, LLC | 3 | $94 |
| Ferring Pharmaceuticals Inc. | 5 | $82 |
| Daiichi Sankyo Inc. | 4 | $63 |
| Braintree Laboratories, Inc. | 4 | $59 |
| Intercept Pharmaceuticals, Inc. | 3 | $52 |
| Novo Nordisk | 2 | $50 |
| Redhill Biopharma Inc. | 2 | $35 |
| Merck | 2 | $31 |
| Alfasigma USA, Inc. | 2 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Ardelyx, Inc. | 1 | $26 |
| UCB, Inc. | 1 | $23 |
| Ironwood Pharmaceuticals, Inc | 1 | $19 |
| Nestle Healthcare Nutrition Inc. | 1 | $18 |
| Sanofi | 1 | $18 |
| Fresenius Kabi USA, LLC | 1 | $18 |
| Evoke Pharma, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,920 in reported general payments places this provider in the 70th percentile of 492 gastroenterology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 43 | $476 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 14 | $291 |
| Esomeprazole Magnesium | 14 | $215 |
| Omeprazole | 25 | $172 |
| Metronidazole | 12 | $155 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Cumming
- Clive AlbertCumming$30K
- Douglas WolfAtlanta$6.4M
- Aasim SheikhMarietta$6M
- Shahriar SedghiMacon$5.4M
- Jeffrey WilliamsAthens$2.5M
- Michael GalambosAtlanta$1.8M
- Nitin GuptaAtlanta$1.7M
- Bruce SalzbergSuwanee$1.4M
- Heba IskandarAtlanta$978K
- David RausherDecatur$907K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.